Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 426 entries
Sorted by: Best Match Show Resources per page
Association of GSTO1 and GSTO2 Polymorphism with Risk of End-Stage Renal Disease Development and Patient Survival.

Journal of medical biochemistry

Cimbaljevic S, Suvakov S, Matic M, Pljesa-Ercegovac M, Pekmezovic T, Radic T, Coric V, Damjanovic T, Dimkovic N, Markovic R, Savic-Radojevic A, Simic T.
PMID: 28356881
J Med Biochem. 2016 Sep;35(3):302-311. doi: 10.1515/jomb-2016-0009. Epub 2016 Jul 06.

BACKGROUND: Oxidative stress in patients with end-stage renal disease (ESRD) is associated with long-term cardiovascular complications. The cytosolic family of glutathione S-transferases (GSTs) is involved in the detoxication of various toxic compounds and antioxidant protection. GST omega class members,...

Cite
Cimbaljevic S, Suvakov S, Matic M, et al. Association of GSTO1 and GSTO2 Polymorphism with Risk of End-Stage Renal Disease Development and Patient Survival. J Med Biochem. 2016;35(3):302-311doi: 10.1515/jomb-2016-0009.
Cimbaljevic, S., Suvakov, S., Matic, M., Pljesa-Ercegovac, M., Pekmezovic, T., Radic, T., Coric, V., Damjanovic, T., Dimkovic, N., Markovic, R., Savic-Radojevic, A., & Simic, T. (2016). Association of GSTO1 and GSTO2 Polymorphism with Risk of End-Stage Renal Disease Development and Patient Survival. Journal of medical biochemistry, 35(3), 302-311. https://doi.org/10.1515/jomb-2016-0009
Cimbaljevic, Slavica, et al. "Association of GSTO1 and GSTO2 Polymorphism with Risk of End-Stage Renal Disease Development and Patient Survival." Journal of medical biochemistry vol. 35,3 (2016): 302-311. doi: https://doi.org/10.1515/jomb-2016-0009
Cimbaljevic S, Suvakov S, Matic M, Pljesa-Ercegovac M, Pekmezovic T, Radic T, Coric V, Damjanovic T, Dimkovic N, Markovic R, Savic-Radojevic A, Simic T. Association of GSTO1 and GSTO2 Polymorphism with Risk of End-Stage Renal Disease Development and Patient Survival. J Med Biochem. 2016 Sep;35(3):302-311. doi: 10.1515/jomb-2016-0009. Epub 2016 Jul 06. PMID: 28356881; PMCID: PMC5346808.
Copy Download .nbib Format: NLM
Challenges in the delivery of therapies to melanoma brain metastases.

Current pharmacology reports

Gampa G, Vaidhyanathan S, Resman BW, Parrish KE, Markovic SN, Sarkaria JN, Elmquist WF.
PMID: 28546917
Curr Pharmacol Rep. 2016 Dec;2(6):309-325. doi: 10.1007/s40495-016-0072-z. Epub 2016 Nov 09.

Brain metastases are a major cause of morbidity and mortality in patients with advanced melanoma. Recent approval of several molecularly-targeted agents and biologics has brought hope to patients with this previously untreatable disease. However, patients with symptomatic melanoma brain...

Cite
Gampa G, Vaidhyanathan S, Resman BW, et al. Challenges in the delivery of therapies to melanoma brain metastases. Curr Pharmacol Rep. 2016;2(6):309-325doi: 10.1007/s40495-016-0072-z.
Gampa, G., Vaidhyanathan, S., Resman, B. W., Parrish, K. E., Markovic, S. N., Sarkaria, J. N., & Elmquist, W. F. (2016). Challenges in the delivery of therapies to melanoma brain metastases. Current pharmacology reports, 2(6), 309-325. https://doi.org/10.1007/s40495-016-0072-z
Gampa, Gautham, et al. "Challenges in the delivery of therapies to melanoma brain metastases." Current pharmacology reports vol. 2,6 (2016): 309-325. doi: https://doi.org/10.1007/s40495-016-0072-z
Gampa G, Vaidhyanathan S, Resman BW, Parrish KE, Markovic SN, Sarkaria JN, Elmquist WF. Challenges in the delivery of therapies to melanoma brain metastases. Curr Pharmacol Rep. 2016 Dec;2(6):309-325. doi: 10.1007/s40495-016-0072-z. Epub 2016 Nov 09. PMID: 28546917; PMCID: PMC5440090.
Copy Download .nbib Format: NLM
SUPERCONDUCTIVITY. Randomness rules.

Science (New York, N.Y.)

Markovic N.
PMID: 26516266
Science. 2015 Oct 30;350(6260):509. doi: 10.1126/science.aad4136.

No abstract available.

Cite
Markovic N. SUPERCONDUCTIVITY. Randomness rules. Science. 2015;350(6260):509doi: 10.1126/science.aad4136.
Markovic, N. (2015). SUPERCONDUCTIVITY. Randomness rules. Science (New York, N.Y.), 350(6260), 509. https://doi.org/10.1126/science.aad4136
Markovic, Nina. "SUPERCONDUCTIVITY. Randomness rules." Science (New York, N.Y.) vol. 350,6260 (2015): 509. doi: https://doi.org/10.1126/science.aad4136
Markovic N. SUPERCONDUCTIVITY. Randomness rules. Science. 2015 Oct 30;350(6260):509. doi: 10.1126/science.aad4136. PMID: 26516266.
Copy Download .nbib Format: NLM
Evaluation of the SIOPEN semi-quantitative scoring system in planar simpatico-adrenal MIBG scintigraphy in children with neuroblastoma.

Neoplasma

Radovic B, Artiko V, Sobic-Saranovic D, Trajkovic G, Markovic S, Vujic D, Obradovic V.
PMID: 25866225
Neoplasma. 2015;62(3):449-55. doi: 10.4149/neo_2015_053.

Neuroblastoma is the most common malignancy in children comprising 7.6% of all infantile cancers. MIBG scintigraphy is a mandatory neuroblastoma diagnostic test, which is among others methods, semi-quantified by the SIOPEN method. The aim of this study was to...

Cite
Radovic B, Artiko V, Sobic-Saranovic D, et al. Evaluation of the SIOPEN semi-quantitative scoring system in planar simpatico-adrenal MIBG scintigraphy in children with neuroblastoma. Neoplasma. 2015;62(3):449-55doi: 10.4149/neo_2015_053.
Radovic, B., Artiko, V., Sobic-Saranovic, D., Trajkovic, G., Markovic, S., Vujic, D., & Obradovic, V. (2015). Evaluation of the SIOPEN semi-quantitative scoring system in planar simpatico-adrenal MIBG scintigraphy in children with neuroblastoma. Neoplasma, 62(3), 449-55. https://doi.org/10.4149/neo_2015_053
Radovic, B, et al. "Evaluation of the SIOPEN semi-quantitative scoring system in planar simpatico-adrenal MIBG scintigraphy in children with neuroblastoma." Neoplasma vol. 62,3 (2015): 449-55. doi: https://doi.org/10.4149/neo_2015_053
Radovic B, Artiko V, Sobic-Saranovic D, Trajkovic G, Markovic S, Vujic D, Obradovic V. Evaluation of the SIOPEN semi-quantitative scoring system in planar simpatico-adrenal MIBG scintigraphy in children with neuroblastoma. Neoplasma. 2015;62(3):449-55. doi: 10.4149/neo_2015_053. PMID: 25866225.
Copy Download .nbib Format: NLM
Combined use of clips and nylon snare ("tulip-bundle") as a rescue endoscopic bleeding control in a mallory-weiss syndrome.

Case reports in gastrointestinal medicine

Ivekovic H, Radulovic B, Jankovic S, Markos P, Rustemovic N.
PMID: 25328727
Case Rep Gastrointest Med. 2014;2014:972765. doi: 10.1155/2014/972765. Epub 2014 Sep 25.

Mallory-Weiss syndrome (MWS) accounts for 6-14% of all cases of upper gastrointestinal bleeding. Prognosis of patients with MWS is generally good, with a benign course and rare recurrence of bleeding. However, no strict recommendations exist in regard to the...

Cite
Ivekovic H, Radulovic B, Jankovic S, et al. Combined use of clips and nylon snare ("tulip-bundle") as a rescue endoscopic bleeding control in a mallory-weiss syndrome. Case Rep Gastrointest Med. 2014;2014:972765doi: 10.1155/2014/972765.
Ivekovic, H., Radulovic, B., Jankovic, S., Markos, P., & Rustemovic, N. (2014). Combined use of clips and nylon snare ("tulip-bundle") as a rescue endoscopic bleeding control in a mallory-weiss syndrome. Case reports in gastrointestinal medicine, 2014972765. https://doi.org/10.1155/2014/972765
Ivekovic, Hrvoje, et al. "Combined use of clips and nylon snare ("tulip-bundle") as a rescue endoscopic bleeding control in a mallory-weiss syndrome." Case reports in gastrointestinal medicine vol. 2014 (2014): 972765. doi: https://doi.org/10.1155/2014/972765
Ivekovic H, Radulovic B, Jankovic S, Markos P, Rustemovic N. Combined use of clips and nylon snare ("tulip-bundle") as a rescue endoscopic bleeding control in a mallory-weiss syndrome. Case Rep Gastrointest Med. 2014;2014:972765. doi: 10.1155/2014/972765. Epub 2014 Sep 25. PMID: 25328727; PMCID: PMC4195354.
Copy Download .nbib Format: NLM
Response: "Commentary: Peripartum Cardiomyopathy in Intensive Care Unit: An Update".

Frontiers in medicine

Dinic V, Markovic D, Savic N, Kutlesic M, Janković RJ.
PMID: 27200354
Front Med (Lausanne). 2016 May 03;3:18. doi: 10.3389/fmed.2016.00018. eCollection 2016.

No abstract available.

Cite
Dinic V, Markovic D, Savic N, et al. Response: "Commentary: Peripartum Cardiomyopathy in Intensive Care Unit: An Update". Front Med (Lausanne). 2016;3:18doi: 10.3389/fmed.2016.00018.
Dinic, V., Markovic, D., Savic, N., Kutlesic, M., & Janković, R. J. (2016). Response: "Commentary: Peripartum Cardiomyopathy in Intensive Care Unit: An Update". Frontiers in medicine, 318. https://doi.org/10.3389/fmed.2016.00018
Dinic, Vesna, et al. "Response: "Commentary: Peripartum Cardiomyopathy in Intensive Care Unit: An Update"." Frontiers in medicine vol. 3 (2016): 18. doi: https://doi.org/10.3389/fmed.2016.00018
Dinic V, Markovic D, Savic N, Kutlesic M, Janković RJ. Response: "Commentary: Peripartum Cardiomyopathy in Intensive Care Unit: An Update". Front Med (Lausanne). 2016 May 03;3:18. doi: 10.3389/fmed.2016.00018. eCollection 2016. PMID: 27200354; PMCID: PMC4853431.
Copy Download .nbib Format: NLM
160 W 800 fs Yb:YAG single crystal fiber amplifier without CPA.

Optics express

Markovic V, Rohrbacher A, Hofmann P, Pallmann W, Pierrot S, Resan B.
PMID: 26480102
Opt Express. 2015 Oct 05;23(20):25883-8. doi: 10.1364/OE.23.025883.

We demonstrate a compact and simple two-stage Yb:YAG single crystal fiber amplifier which delivers 160 W average power, 800 fs pulses without chirped pulse amplification. This is the highest average power of femtosecond laser based on SCF. Additionally, we...

Cite
Markovic V, Rohrbacher A, Hofmann P, et al. 160 W 800 fs Yb:YAG single crystal fiber amplifier without CPA. Opt Express. 2015;23(20):25883-8doi: 10.1364/OE.23.025883.
Markovic, V., Rohrbacher, A., Hofmann, P., Pallmann, W., Pierrot, S., & Resan, B. (2015). 160 W 800 fs Yb:YAG single crystal fiber amplifier without CPA. Optics express, 23(20), 25883-8. https://doi.org/10.1364/OE.23.025883
Markovic, Vesna, et al. "160 W 800 fs Yb:YAG single crystal fiber amplifier without CPA." Optics express vol. 23,20 (2015): 25883-8. doi: https://doi.org/10.1364/OE.23.025883
Markovic V, Rohrbacher A, Hofmann P, Pallmann W, Pierrot S, Resan B. 160 W 800 fs Yb:YAG single crystal fiber amplifier without CPA. Opt Express. 2015 Oct 05;23(20):25883-8. doi: 10.1364/OE.23.025883. PMID: 26480102.
Copy Download .nbib Format: NLM
Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response Rates.

F1000Research

Ashdown ML, Robinson AP, Yatomi-Clarke SL, Ashdown ML, Allison A, Abbott D, Markovic SN, Coventry BJ.
PMID: 26834979
F1000Res. 2015 Jul 13;4:232. doi: 10.12688/f1000research.6760.1. eCollection 2015.

Complete response (CR) rates reported for cytotoxic chemotherapy for late-stage cancer patients are generally low, with few exceptions, regardless of the solid cancer type or drug regimen. We investigated CR rates reported in the literature for clinical trials using...

Cite
Ashdown ML, Robinson AP, Yatomi-Clarke SL, et al. Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response Rates. F1000Res. 2015;4:232doi: 10.12688/f1000research.6760.1.
Ashdown, M. L., Robinson, A. P., Yatomi-Clarke, S. L., Ashdown, M. L., Allison, A., Abbott, D., Markovic, S. N., & Coventry, B. J. (2015). Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response Rates. F1000Research, 4232. https://doi.org/10.12688/f1000research.6760.1
Ashdown, Martin L, et al. "Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response Rates." F1000Research vol. 4 (2015): 232. doi: https://doi.org/10.12688/f1000research.6760.1
Ashdown ML, Robinson AP, Yatomi-Clarke SL, Ashdown ML, Allison A, Abbott D, Markovic SN, Coventry BJ. Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response Rates. F1000Res. 2015 Jul 13;4:232. doi: 10.12688/f1000research.6760.1. eCollection 2015. PMID: 26834979; PMCID: PMC4706056.
Copy Download .nbib Format: NLM
Graphene Aerogels Decorated with α-FeOOH Nanoparticles for Efficient Adsorption of Arsenic from Contaminated Waters.

ACS applied materials & interfaces

Andjelkovic I, Tran DN, Kabiri S, Azari S, Markovic M, Losic D.
PMID: 25871444
ACS Appl Mater Interfaces. 2015 May 13;7(18):9758-66. doi: 10.1021/acsami.5b01624. Epub 2015 Apr 28.

Arsenic (As) is the world's most hazardous chemical found in drinking water of many countries; therefore, there is an urgent need for the development of low-cost adsorbents for its removal. Here, we report a highly versatile and synthetic route...

Cite
Andjelkovic I, Tran DN, Kabiri S, et al. Graphene Aerogels Decorated with α-FeOOH Nanoparticles for Efficient Adsorption of Arsenic from Contaminated Waters. ACS Appl Mater Interfaces. 2015;7(18):9758-66doi: 10.1021/acsami.5b01624.
Andjelkovic, I., Tran, D. N., Kabiri, S., Azari, S., Markovic, M., & Losic, D. (2015). Graphene Aerogels Decorated with α-FeOOH Nanoparticles for Efficient Adsorption of Arsenic from Contaminated Waters. ACS applied materials & interfaces, 7(18), 9758-66. https://doi.org/10.1021/acsami.5b01624
Andjelkovic, Ivan, et al. "Graphene Aerogels Decorated with α-FeOOH Nanoparticles for Efficient Adsorption of Arsenic from Contaminated Waters." ACS applied materials & interfaces vol. 7,18 (2015): 9758-66. doi: https://doi.org/10.1021/acsami.5b01624
Andjelkovic I, Tran DN, Kabiri S, Azari S, Markovic M, Losic D. Graphene Aerogels Decorated with α-FeOOH Nanoparticles for Efficient Adsorption of Arsenic from Contaminated Waters. ACS Appl Mater Interfaces. 2015 May 13;7(18):9758-66. doi: 10.1021/acsami.5b01624. Epub 2015 Apr 28. PMID: 25871444.
Copy Download .nbib Format: NLM
Infused autograft lymphocyte to monocyte ratio predicts survival in classical Hodgkin lymphoma.

Journal of blood medicine

Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Hogan WJ, Markovic SN.
PMID: 25674021
J Blood Med. 2015 Feb 02;6:45-53. doi: 10.2147/JBM.S75784. eCollection 2015.

The infused autograft lymphocyte to monocyte ratio (A-LMR) as a surrogate marker of host immunity (ie, absolute lymphocyte count) and CD14+ HLA-DR(low/neg) immunosuppressive monocytes (ie, absolute monocyte count) is a prognostic factor for patients with diffuse large B-cell lymphoma...

Cite
Porrata LF, Inwards DJ, Ansell SM, et al. Infused autograft lymphocyte to monocyte ratio predicts survival in classical Hodgkin lymphoma. J Blood Med. 2015;6:45-53doi: 10.2147/JBM.S75784.
Porrata, L. F., Inwards, D. J., Ansell, S. M., Micallef, I. N., Johnston, P. B., Hogan, W. J., & Markovic, S. N. (2015). Infused autograft lymphocyte to monocyte ratio predicts survival in classical Hodgkin lymphoma. Journal of blood medicine, 645-53. https://doi.org/10.2147/JBM.S75784
Porrata, Luis F, et al. "Infused autograft lymphocyte to monocyte ratio predicts survival in classical Hodgkin lymphoma." Journal of blood medicine vol. 6 (2015): 45-53. doi: https://doi.org/10.2147/JBM.S75784
Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Hogan WJ, Markovic SN. Infused autograft lymphocyte to monocyte ratio predicts survival in classical Hodgkin lymphoma. J Blood Med. 2015 Feb 02;6:45-53. doi: 10.2147/JBM.S75784. eCollection 2015. PMID: 25674021; PMCID: PMC4321658.
Copy Download .nbib Format: NLM
Quantum phase slips in superconducting nanowires.

Physical review letters

Lau CN, Markovic N, Bockrath M, Bezryadin A, Tinkham M.
PMID: 11736371
Phys Rev Lett. 2001 Nov 19;87(21):217003. doi: 10.1103/PhysRevLett.87.217003. Epub 2001 Nov 02.

We have measured the resistance vs temperature of more than 20 superconducting nanowires with nominal widths ranging from 10 to 22 nm and lengths from 100 nm to 1 microm. With decreasing cross-sectional areas, the wires display increasingly broad...

Cite
Lau CN, Markovic N, Bockrath M, et al. Quantum phase slips in superconducting nanowires. Phys Rev Lett. 2001;87(21):217003doi: 10.1103/PhysRevLett.87.217003.
Lau, C. N., Markovic, N., Bockrath, M., Bezryadin, A., & Tinkham, M. (2001). Quantum phase slips in superconducting nanowires. Physical review letters, 87(21), 217003. https://doi.org/10.1103/PhysRevLett.87.217003
Lau, C N, et al. "Quantum phase slips in superconducting nanowires." Physical review letters vol. 87,21 (2001): 217003. doi: https://doi.org/10.1103/PhysRevLett.87.217003
Lau CN, Markovic N, Bockrath M, Bezryadin A, Tinkham M. Quantum phase slips in superconducting nanowires. Phys Rev Lett. 2001 Nov 19;87(21):217003. doi: 10.1103/PhysRevLett.87.217003. Epub 2001 Nov 02. PMID: 11736371.
Copy Download .nbib Format: NLM
Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma.

Journal of translational medicine

Markovic SN, Dietz AB, Greiner CW, Maas ML, Butler GW, Padley DJ, Bulur PA, Allred JB, Creagan ET, Ingle JN, Gastineau DA, Vuk-Pavlovic S.
PMID: 16911798
J Transl Med. 2006 Aug 15;4:35. doi: 10.1186/1479-5876-4-35.

BACKGROUND: Dendritic cells (DCs) have been used as vaccines in clinical trials of immunotherapy of cancer and other diseases. Nonetheless, progress towards the use of DCs in the clinic has been slow due in part to the absence of...

Cite
Markovic SN, Dietz AB, Greiner CW, et al. Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma. J Transl Med. 2006;4:35doi: 10.1186/1479-5876-4-35.
Markovic, S. N., Dietz, A. B., Greiner, C. W., Maas, M. L., Butler, G. W., Padley, D. J., Bulur, P. A., Allred, J. B., Creagan, E. T., Ingle, J. N., Gastineau, D. A., & Vuk-Pavlovic, S. (2006). Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma. Journal of translational medicine, 435. https://doi.org/10.1186/1479-5876-4-35
Markovic, Svetomir N, et al. "Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma." Journal of translational medicine vol. 4 (2006): 35. doi: https://doi.org/10.1186/1479-5876-4-35
Markovic SN, Dietz AB, Greiner CW, Maas ML, Butler GW, Padley DJ, Bulur PA, Allred JB, Creagan ET, Ingle JN, Gastineau DA, Vuk-Pavlovic S. Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma. J Transl Med. 2006 Aug 15;4:35. doi: 10.1186/1479-5876-4-35. PMID: 16911798; PMCID: PMC1570143.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 426 entries